Costello Syndrome Latest Advances
Find the Latest Research About Costello Syndrome
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 640 publications
Genetic Characterization of Familial and Multifactorial Chylomicronemia in Taiwanese Patients with Severe Hypertriglyceridemia.
Journal: Journal of atherosclerosis and thrombosis
Published: October 22, 2026
Targeting Nitric Oxide Synthase 2 Reverses Learning Deficits in an Oligodendrocyte-Focused Model of Costello Syndrome.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Functional characterization of hypertriglyceridemia-associated mutations in Lipase Maturation Factor 1 by a second-generation activity assay.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Functional characterization of hypertriglyceridemia-associated mutations in LMF1 by a second-generation activity assay.
Journal: Journal of lipid research
Published: September 05, 2026
Content validity of the Familial Chylomicronemia Syndrome Symptoms and Impacts Scale (FCS-SIS) for severe hypertriglyceridemia (sHTG).
Journal: Patient related outcome measures
Published: September 04, 2026
Deficiency of the Lipoprotein Lipase Pathway Modifies the Phenotypic Expression of Genetically Determined Lipoprotein(a).
Journal: Journal of lipid research
Published: August 12, 2026
Facial papillomatous thickening and strawberry-like gingival hyperplasia in Costello syndrome.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 22, 2026
Olezarsen and Plozasiran: Novel apoC-III targeting medications for the treatment of hypertriglyceridemia.
Journal: Journal of cardiovascular pharmacology
Published: July 06, 2026
Familial Chylomicronemia Syndrome Due to a Homozygous LPL c.644G>A Variant and Response to Volanesorsen in Colombia: A Case Report.
Journal: Cureus
Published: June 21, 2026
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
Journal: The Annals of pharmacotherapy
Published: June 06, 2026
Last Updated: 11/08/2026